Alexander M. Reznik

Vartanov A.V., Krysko M.D., Leonovich D.A., Shevaldova O.V., Савенкова V.I., Ochneva A.G., Reznik A.M.

Features of the organization of the default system of the brain in connection with the severity of delusions and hallucinations in schizophrenia

Clinical Psychology and Special Education (2025. Vol. 14, no. 3, pp. 136–153)

DOI

10.17759/cpse.2025140309

123

Reznik A.M., Karpenko O.A., Shumakova E.A., Mudrak A.V., Sokolov A.V., Nazimova S.V., Sayfulina A.M., Eliseenko A.M., Matvievskaya T.K., Khannanova A.N., Revenko V.I., Shcherbakov D.V., Martynyuk Y.L., Arbuzov A.L., Yatsenko O.A., Alekseeva P.N., Berdalin A.B., Burygina L.A.

Dynamics of Clinical Manifestations and Social Functioning in Schizophrenia: A Non-interventional Observational Study of Paliperidone Palmitat Dosage Forms

Consortium Psychiatricum (2024. Vol. 5, no. 4, pp. 16–38)

DOI

10.17816/CP15567

46

Telesheva K.Y., Савенкова V.I., Morozova I.O., Ochneva A.G., Zeltser A.I., Andreyuk D.S., Reznik A.M., Mukhin V.N., Melkonian G.G., Lytkina K.A., Mitrofanov A.A., Morozova A.Yu.

Potential Neurophysiological Markers of Combat-Related Post-Traumatic Stress Disorder: A Cross-Sectional Diagnostic Study

Consortium Psychiatricum (2024. Vol. 5, no. 2, pp. 31–44)

DOI

10.17816/CP15512

77

Reznik A.M., Arbuzov A.L., Murin S.P.

Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment

Consortium Psychiatricum (2020. Vol. 1, no. 2, pp. 43–51)

61

Anna, Stekolshchikova E.A., Morozova A.Yu., Anikanov N., Alekseeva P.N., Khobta E.B., Andreyuk D.S., Zozulya S.A., Barkhatova A.N., Klyushnik T.P., Reznik A.M., Kostyuk G.P., Khaitovich P.

Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia

Consortium Psychiatricum (2021. Vol. 2, no. 3, pp. 35–43)

DOI

10.17816/CP101

45

Reznik A.M., Syunyakov T.S., Arbuzov A.L.

Alcohol Addiction in War Veterans Treated in a In-patient Psychiatric Facility: Incidence, Comorbidity with PTSD Symptoms, Association with Combat Stressors

Consortium Psychiatricum (2022. Vol. 3, no. 3, pp. 73–89)

DOI

10.17816/CP188

132

Reznik A.M., Syunyakov T.S., Akhmerova I.Yu., Butylin D.Yu., Vasilenko A.O., Gvozdetckii A.N., Gizatullin T.R., Gilmanshina G.V., Golosov E.A., Kolchev S.A., Linova L.P., Miron D.V., Mudrak A.V., Oleichik I.V., Sizov S.V., Tarakanova E.A., Chesnokova O.I.

Clinical Effectiveness of Lurasidone Monotherapy in Patients with Acute Episodes of Schizophrenia and Associated Symptoms of Depression

Consortium Psychiatricum (2022. Vol. 3, no. 3, pp. 58–72)

DOI

10.17816/CP172

195

Reznik A.M., Syunyakov T.S., Mudrak A.V., Zakharov N.B., Popova Zh.B., Khoroshilova A.N., Khurbatova I.G., Sayfulina A.M., Eliseenko A.M., Matvievskaya T.K., Khannanova A.N.

Treatment of Depression with Vortioxetine and Second Generation Antipsychotics During the Period of Remission Formation in Schizophrenia (Interim Data Analysis)

Consortium Psychiatricum (2023. Vol. 4, no. 1, pp. 18–36)

DOI

10.17816/CP3728

52